Cannabis and Hemp Industry Investment News
A 29% revenue increase during its third quarter helped propel the cannabis analytics firm higher on Friday Also moving was The Green Organic Dutchman,...
The company also narrowed its adjusted-EBITDA loss by about 64% from the 2Q and saw its first-ever month of positive adjusted-EBITDA in August CB2 sai...
Its clinical data management software and electronic data capture tools will be integrated to create a better understanding of VIVO’s medical patient ...
What are you searching for? viewCB2 Insights Inc. (CSE:CBII-OTCQB: CBIIF) CEO Prad Sekar joined Steve Darling from Proactive Vancouver to discuss the ...
CB2 will license its technology to the UK's MyAccess Clinics to manage their patient data. Cannabis stocks trended lower on Thursday across the US and...
MyAccess Clinics operates multiple clinics in the UK and is focused on providing care for patients with unmet needs The firm's Electronic Data Capture...
It also appointed Dr Paola Cubillos, a prominent Colombian naturopathic and integrative medicine physician, as its medical director in the country Col...
For the quarter ended June 30, CB2 said its revenue was C$3.3 million, a 14.3% increase over the previous quarter The Toronto-based company gathers po...
What are you searching for? viewCB2 Insights Inc. Buds today are () (OTCQB:CBIIF), Cannvas MedTech Inc () (OTCMKTS:CANVF). Duds are Canopy Growth Corp...
Peter Cummins worked for more than two decades at Johnson & Johnson in a variety of executive roles The appointment brings the size of CB2’s board...
Also on the move were Cannvas MedTech, Harvest Health & Recreation, Canopy Growth and Choom CB2 Insights rose as it named former J&J executive...
